{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:15:19Z","timestamp":1787966119909,"version":"build-2784847793"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/fyjj5585","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T03:13:17Z","timestamp":1727579597000},"page":"4788-4795","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic value of the Controlling Nutritional Status score in patients with newly diagnosed multiple myeloma"],"prefix":"10.62347","volume":"16","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","unstructured":"Palumbo A and Anderson K. Multiple myeloma. N Engl J Med 2011; 364: 1046-1060.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/cancers13112712","article-title":"Rapid progress in immunotherapies for multiple myeloma: an updated comprehensive review","volume":"13","author":"Nishida","year":"2021","unstructured":"Nishida H. Rapid progress in immunotherapies for multiple myeloma: an updated comprehensive review. Cancers (Basel) 2021; 13: 2712.","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-med-070209-175325","article-title":"Multiple myeloma","volume":"62","author":"Laubach","year":"2011","unstructured":"Laubach J, Richardson P and Anderson K. Multiple myeloma. Annu Rev Med 2011; 62: 249-264.","journal-title":"Annu Rev Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"de Donk NWCJ","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C and Yong KL. Multiple myeloma. Lancet 2021; 397: 410-427.","journal-title":"Lancet"},{"key":"ref4","unstructured":"Chinese Hematology Association; Chinese Society of Hematology. [Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)]. Zhonghua Nei Ke Za Zhi 2022; 61: 480-487."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG and Miguel JF. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538-548.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"ref6","unstructured":"Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F and Fernández G. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005; 20: 38-45."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/16078454.2022.2078040","article-title":"Prognostic role of controlling nutritional status score in hematological malignancies","volume":"27","author":"Zhang","year":"2022","unstructured":"Zhang Y, Chen Q, Lu C and Yu L. Prognostic role of controlling nutritional status score in hematological malignancies. Hematology 2022; 27: 653-658.","journal-title":"Hematology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00277-019-03844-2","article-title":"Clinical impact of the CONUT score in patients with multiple myeloma","volume":"99","author":"Okamoto","year":"2020","unstructured":"Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E and Kimura S. Clinical impact of the CONUT score in patients with multiple myeloma. Ann Hematol 2020; 99: 113-119.","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1080\/10428194.2020.1749608","article-title":"The prognostic value of the controlling nutritional status score in patients with multiple myeloma","volume":"61","author":"Kamiya","year":"2020","unstructured":"Kamiya T, Ito C, Fujita Y, Ogura S, Mizuno K, Sakurai A, Aisa Y and Nakazato T. The prognostic value of the controlling nutritional status score in patients with multiple myeloma. Leuk Lymphoma 2020; 61: 1894-1900.","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/CBM-210073","article-title":"Association between baseline controlling nutritional status score and clinical outcomes of patients with multiple myeloma","volume":"32","author":"Zhou","year":"2021","unstructured":"Zhou X, Lu Y, Xia J, Mao J, Wang J and Guo H. Association between baseline controlling nutritional status score and clinical outcomes of patients with multiple myeloma. Cancer Biomark 2021; 32: 65-71.","journal-title":"Cancer Biomark"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.3390\/nu13114086","article-title":"Comparison of preoperative nutritional indexes for outcomes after primary esophageal surgery for esophageal squamous cell carcinoma","volume":"13","author":"Yoon","year":"2021","unstructured":"Yoon JP, Nam JS, Abidin MFBZ, Kim SO, Lee EH, Choi IC and Chin JH. Comparison of preoperative nutritional indexes for outcomes after primary esophageal surgery for esophageal squamous cell carcinoma. Nutrients 2021; 13: 4086.","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jpen.2199","article-title":"Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: a prospective study","volume":"46","author":"de Sousa","year":"2022","unstructured":"de Sousa IM, Silva FM, de Carvalho ALM, da Rocha IMG and Fayh APT. Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: a prospective study. JPEN J Parenter Enteral Nutr 2022; 46: 508-516","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1080\/01635581.2022.2059089","article-title":"Malnutrition and weight loss as prognostic factors in the survival of patients with gastric cancer","volume":"74","author":"Nikniaz","year":"2022","unstructured":"Nikniaz Z, Somi MH and Naghashi S. Malnutrition and weight loss as prognostic factors in the survival of patients with gastric cancer. Nutr Cancer 2022; 74: 3140-3145.","journal-title":"Nutr Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/nu14010207","article-title":"Malnutrition and increased risk of adverse outcomes in elderly patients undergoing elective colorectal cancer surgery: a case-control study nested in a cohort","volume":"14","author":"Mart&#xED","year":"2022","unstructured":"Martínez-Escribano C, Arteaga Moreno F, Pérez-López M, Cunha-Pérez C, Belenguer-Varea Á, Cuesta Peredo D, Blanco González FJ and Tarazona-Santabalbina FJ. Malnutrition and increased risk of adverse outcomes in elderly patients undergoing elective colorectal cancer surgery: a case-control study nested in a cohort. Nutrients 2022; 14: 207.","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"952802","DOI":"10.3389\/fimmu.2022.952802","article-title":"Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: a systematic review and meta-analysis","volume":"13","author":"Lu","year":"2022","unstructured":"Lu C, Chen Q, Fei L, Wang J, Wang C and Yu L. Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: a systematic review and meta-analysis. Front Immunol 2022; 13: 952802.","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hon.2732","article-title":"Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma","volume":"38","author":"Nagata","year":"2020","unstructured":"Nagata A, Kanemasa Y, Sasaki Y, Nakamura S, Okuya T, Funasaka C, Kageyama A, Shimoyama T and Omuro Y. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma. Hematol Oncol 2020; 38: 309-317.","journal-title":"Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00277-020-04262-5","article-title":"Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma","volume":"99","author":"Matsukawa","year":"2020","unstructured":"Matsukawa T, Suto K, Kanaya M, Izumiyama K, Minauchi K, Yoshida S, Oda H, Miyagishima T, Mori A, Ota S, Hashimoto D and Teshima T; North Japan Hematology Study Group (NJHSG). Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol 2020; 99: 2859-2868.","journal-title":"Ann Hematol"},{"key":"ref18","unstructured":"Liang F, Dong XY, Tang GF, Qi KM, Chen W, Sang W, Sun HY, Cao J, Cheng H, Li DP, Li ZY and Xu KL. Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma. Zhonghua Xue Ye Xue Za Zhi 2021; 42: 332-337."},{"key":"ref19","unstructured":"Li YQ, Wang Y, Song Y, Han Y, Li JJ, Yue LL, Zeng PY, Wu CY and Chai Y. The influence of CONUT Score on the prognosis of patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2021; 29: 781-786."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/bloodadvances.2022008021","article-title":"Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma","volume":"7","author":"Edwards","year":"2023","unstructured":"Edwards CV, Hassan H, Yildirim C, Ferri G, Verma KP, Murray Horwitz ME, Fillmore NR and Munshi NC. Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma. Blood Adv 2023; 7: 482-490.","journal-title":"Blood Adv"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wong TW, Kita H, Hanson CA, Walters DK, Arendt BK and Jelinek DF. Induction of malignant plasma cell proliferation by eosinophils. PLoS One 2013; 8: e70554.","DOI":"10.1371\/journal.pone.0070554"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Wong D, Winter O, Hartig C, Siebels S, Szyska M, Tiburzy B, Meng L, Kulkarni U, Fähnrich A, Bommert K, Bargou R, Berek C, Chu VT, Bogen B, Jundt F and Manz RA. Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow niches. PLoS One 2014; 9: e109018.","DOI":"10.1371\/journal.pone.0109018"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1038\/s41467-018-07305-8","article-title":"Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression","volume":"9","author":"Calcinotto","year":"2018","unstructured":"Calcinotto A, Brevi A, Chesi M, Ferrarese R, Garcia Perez L, Grioni M, Kumar S, Garbitt VM, Sharik ME, Henderson KJ, Tonon G, Tomura M, Miwa Y, Esplugues E, Flavell RA, Huber S, Canducci F, Rajkumar VS, Bergsagel PL and Bellone M. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nat Commun 2018; 9: 4832.","journal-title":"Nat Commun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"48350","DOI":"10.18632\/oncotarget.16237","article-title":"High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma","volume":"8","author":"Gu","year":"2017","unstructured":"Gu Y, Yuan YH, Xu J, Shi QL, Qu XY, Guo R, Bai H, Xu JD, Li JY and Chen LJ. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma. Oncotarget 2017; 8: 48350-48361.","journal-title":"Oncotarget"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-0609.2010.01466.x","article-title":"High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents","volume":"85","author":"Terpos","year":"2010","unstructured":"Terpos E, Katodritou E, Roussou M, Pouli A, Michalis E, Delimpasi S, Parcharidou A, Kartasis Z, Zomas A, Symeonidis A, Viniou NA, Anagnostopoulos N, Economopoulos T, Zervas K and Dimopoulos MA; Greek Myeloma Study Group, Greece. High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents. Eur J Haematol; 2010; 85: 114-119.","journal-title":"Eur J Haematol"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Murray MJ, Huddart RA and Coleman N. The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol 2016; 3: 715-725.","DOI":"10.1038\/nrurol.2016.170"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00277-010-1130-y","article-title":"Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival","volume":"90","author":"Barlogie","year":"2011","unstructured":"Barlogie B, Bolejack V, Schell M and Crowley J. Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival. Ann Hematol 2011; 90: 423-428.","journal-title":"Ann Hematol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/9\/ajtr0154261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:52Z","timestamp":1766022952000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/9\/ajtr0154261.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/fyjj5585","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}